Global RNA Analysis Transcriptomics Market

Report ID : 1403 | Published : 2022-10-13 | Pages: | Format: PDF/EXCEL

The market size of the global RNA Analysis Transcriptomics market in the year 2021 is valued at 8.42 billion and is predicted to reach 35.28 billion by the year 2030 at an 17.53% CAGR during the forecast period.

The set of transcripts present in every human is known as transcriptomics, and the term refers to examining every transcript molecule. The RNA analysis transcriptome enables researchers to precisely analyze each gene's gene distribution and function in an organism. It is projected that developments in the field of transcriptomics, such as the widespread application of RNA-sequencing, and an increase in the number of transcriptomics applications, such as drug discovery, will boost the global RNA analysis transcriptomics market. The global RNA analysis transcriptomics market is expanding due to increased financing and grants from numerous corporate and public entities. The market is anticipated to rise as the focus on toxicogenomic and biomarker identification increases and interest in outsourcing services. The global RNA analysis transcriptomics market is expanding due to the rising demand for personalized medicine, increased pharmaceutical and biotechnology R&D spending, government funding for omics, a rise in RNA sequencing applications, and the creation of new transcriptomics products by a significant number of key players. However, during the projection period, the global market is anticipated to be constrained by high capital investment needs and data management problems. Over the expected timeframe, business growth is projected to be significantly impacted by the lack of qualified practitioners and high startup expenses.

Market Segmentation:

The RNA Analysis Transcriptomics market is segmented on the type, technology and application. Based on type, the market is segmented into Consumables, Instruments, Software and Services. Based on technology, the RNA Analysis Transcriptomics market is segmented into Microarrays, qPCR and Sequencing Technology. Based on the application, the RNA Analysis Transcriptomics market is segmented into Drug Discovery, Diagnostics, Disease Profiling and Others.

Based on product, the Consumables segment is accounted as a significant contributor to the RNA Analysis Transcriptomics market.

The market is segmented based on type: Consumables, Instruments, Software and Services. It is predicted that the consumables category will contribute more to global revenues in the market. High-quality reagents are increasingly in demand for transcriptome investigations, and media and reagents are used often. In addition, rising government spending on life science research, advancing omics research and expanding pharmaceutical R&D all contribute to the growth of the consumables industry.

The sequencing technology segment witnessed growth at a rapid rate.

Based on technology, the RNA Analysis Transcriptomics market is segmented into Microarrays, qPCR and Sequencing Technology. The market segment for sequencing technologies is anticipated to develop at the fastest rate during the forecast period. Target identification and drug discovery applications are better suited to RNA sequencing's egalitarian technology and ability to provide direct access to mRNA sequences. RNA sequencing also aids in resolving several problems with microarrays, including bias and variance brought on by inefficient labeling and hybridization. This sector's technological developments are also expected to fuel market expansion.

The North American RNA Analysis Transcriptomics market holds a significant revenue share in the region.

The North American RNA Analysis Transcriptomics market is expected to register the highest market share in revenue in the near future. Growing academic and governmental investments in genomes and proteomics research, high funding levels for life science research, high biopharmaceutical R&D expenditures, and greater uptake of cutting-edge technologies in North America contribute to the expansion. Transcriptomics-related R&D expenditures in the private sector are steadily rising, enabling local market actors to produce customized treatments. The presence of numerous international players in this region is another crucial factor contributing to this market segment's considerable share of RNA analysis transcriptomics. In addition, Asia Pacific is projected to grow rapidly in the global RNA Analysis Transcriptomics market because there are more biotech and pharmaceutical businesses in the region, which will increase demand for transcriptomics technologies and drive up investment in R&D for new pharmaceuticals. Government and business sector investment in biotechnology research is rising in the Asia Pacific. In addition to providing financing for biotechnology research, the Japanese government and non-governmental organizations also aggressively support the nation's medical and life sciences efforts. This motivates scientists to pursue the topic of transcriptomics aggressively.

Competitive Landscape

The key players in the RNA Analysis Transcriptomics market have shifted their focus toward product manufacturing and are initiating significant strategies such as mergers, acquisitions, and joint ventures of major and domestic players to enhance their product portfolio and strengthen their global market footprint. Some major key players in the RNA Analysis Transcriptomics market are Agilent Technologies Inc., Bio-Rad Laboratories, F-Hoffmann La-Roche, Fluidigm Corporation, General Electric Company, Illuminia Inc., Merck & Co. Inc, Promega Corporation, Qiagen, Inc. and Thermofisher Scientific.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global RNA Analysis Transcriptomics Market Snapshot

Chapter 4. Global RNA Analysis Transcriptomics Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis

5.1. by Product Type & Market Share, 2019 & 2030

5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by Product Type:

5.2.1. Consumables

5.2.2. Instruments

5.2.3. Software

5.2.4. Services

Chapter 6. Market Segmentation 2: by Technology Estimates & Trend Analysis

6.1. by Technology & Market Share, 2019 & 2030

6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by Technology:

6.2.1. Microarrays

6.2.2. qPCR

6.2.3. Sequencing Technology

Chapter 7. Market Segmentation 3: by Application Estimates & Trend Analysis

7.1. by Application & Market Share, 2019 & 2030

7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2030 for the following by Application:

7.2.1. Drug Discovery

7.2.2. Diagnostics and Disease Profiling

7.2.3. Others

Chapter 8. RNA Analysis Transcriptomics Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America RNA Analysis Transcriptomics Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2022-2030

8.1.2. North America RNA Analysis Transcriptomics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2022-2030

8.1.3. North America RNA Analysis Transcriptomics Market revenue (US$ Million) by Application, 2022-2030

8.1.4. North America RNA Analysis Transcriptomics Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2030

8.2. Europe

8.2.1. Europe RNA Analysis Transcriptomics Market revenue (US$ Million) by Product Type, 2022-2030

8.2.2. Europe RNA Analysis Transcriptomics Market revenue (US$ Million) by Technology, 2022-2030

8.2.3. Europe RNA Analysis Transcriptomics Market revenue (US$ Million) by Application, 2022-2030

8.2.4. Europe RNA Analysis Transcriptomics Market revenue (US$ Million) by country, 2022-2030

8.3. Asia Pacific

8.3.1. Asia Pacific RNA Analysis Transcriptomics Market revenue (US$ Million) by Product Type, 2022-2030

8.3.2. Asia Pacific RNA Analysis Transcriptomics Market revenue (US$ Million) by Technology, 2022-2030

8.3.3. Asia-Pacific RNA Analysis Transcriptomics Market revenue (US$ Million) by Application, 2022-2030

8.3.4. Asia Pacific RNA Analysis Transcriptomics Market revenue (US$ Million) by country, 2022-2030

8.4. Latin America

8.4.1. Latin America RNA Analysis Transcriptomics Market revenue (US$ Million) by Product Type, 2022-2030

8.4.2. Latin America RNA Analysis Transcriptomics Market revenue (US$ Million) by Technology, 2022-2030

8.4.3. Latin America RNA Analysis Transcriptomics Market revenue (US$ Million) by Application, 2022-2030

8.4.4. Latin America RNA Analysis Transcriptomics Market revenue (US$ Million) by country, 2022-2030

8.5. Middle East & Africa

8.5.1. Middle East & Africa RNA Analysis Transcriptomics Market revenue (US$ Million) by Product Type, 2022-2030

8.5.2. Middle East & Africa RNA Analysis Transcriptomics Market revenue (US$ Million) by Technology, 2022-2030

8.5.3. Middle East & Africa RNA Analysis Transcriptomics Market revenue (US$ Million) by Application, 2022-2030

8.5.4. Middle East & Africa RNA Analysis Transcriptomics Market revenue (US$ Million) by country, 2022-2030

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. Agilent Technologies Inc.

9.2.2. Bio-Rad Laboratories

9.2.3. F-Hoffmann La-Roche

9.2.4. Fluidigm Corporation

9.2.5. General Electric Company

9.2.6. Illuminia Inc.

9.2.7. Merck & Co. Inc

9.2.8. Promega Corporation

9.2.9. Qiagen, Inc.

9.2.10. Thermofisher Scientific

9.2.11. Other Prominent Players

By Type-

  • Consumables
  • Instruments
  • Software
  • Services

By Technology-

  • Microarrays
  • qPCR
  • Sequencing Technology

By Application-

  • Drug Discovery
  • Diagnostics and Disease Profiling
  • Others

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?
Our Clients